Amanote Research

Amanote Research

    RegisterSign In

Zinc Transporter HKE4 as a New Target in Antihormone Resistance of Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr1926
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

May 1, 2008

Authors
KM TaylorN JordanS HiscoxJM GeeRI Nicholson
Publisher

Springer Science and Business Media LLC


Related search

Loss of PEDF: A Novel Mechanism of Antihormone Resistance in Breast Cancer

2013English

Obesity Hormone Leptin: A New Target in Breast Cancer?

Breast Cancer Research
Cancer ResearchOncology
2007English

Harnessing Drug Resistance: Using ABC Transporter Proteins to Target Cancer Cells

Biochemical Pharmacology
BiochemistryPharmacology
2007English

Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology
2017English

Tissue Transglutaminase: A New Target to Reverse Cancer Drug Resistance

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2011English

Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2020English

Structure-Function Analysis of HKE4, a Member of the New LIV-1 Subfamily of Zinc Transporters

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2004English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

Lewis Y Antigen as a Target for Breast Cancer Therapy

1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy